beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)

Term ID

CHEBI:142153

Synonyms

a ganglioside SM1a
beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(SO3)-3-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(1-)
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-sulfo-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
Sulfogangliotetraosylceramide(1-)

Definition

References

PMID:7553669

Ontology

ChEBI ( EBI )

Relationships

is a type of: anionic ganglioside organic molecular entity

anionic ganglioside organic molecular entity Show first 5 Terms
has subtype: beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-) beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-) beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-) beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-)

beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:0)(1-) beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d18:1(4E))(1-) beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-) beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)(1-) Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)

Phenotype where environments contain beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)

Phenotype modified by environments containing beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(SO3)-3-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)

Human Disease Model